Views sought on guidelines for genetic testing of human embryos (New Zealand)
By stuff.co.nz,
Stuff (New Zealand)
| 10. 04. 2004
Public consultation begins this week on proposed guidelines covering the testing of human embryos for serious inherited genetic conditions.
The guidelines for pre-implantation genetic diagnosis (PGD) have been formulated by the National Ethics Committee on Assisted Human Reproduction (NECAHR), a statement from the Ministry of Health said today.
PGD is a procedure used to test early human embryos for serious inherited genetic conditions. It can only be used in conjunction with in-vitro fertilisation (IVF).
Public submissions will assist in preparing a final set of guidelines, which will be submitted to health minister Annette King for approval early next year.
The discussion document and proposed guidelines are being distributed to fertility clinics, district health boards, professional organisations, consumer groups, government agencies, and individuals with an interest in the subject.
As well as calling for written submissions, NECAHR is holding a series of public meetings throughout the country to hear oral submissions. These will be held in the four main centres at the end of November.
In June last year, Ms King gave approval in principle for PGD to be offered in...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...